© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
July 06, 2008
A recent meta-analysis of 31 randomized controlled trials with 4500 participants showed that metformin treatment significantly decreased weight, improved dyslipidemia and insulin resistance, and reduced the incidence of new-onset diabetes by 40%, with beneficial effects maintained over time. Further studies will show whether the metabolic improvements achieved with metformin treatment will ultimately result in a decrease in cardiovascular morbidity and mortality.
Can Glasses Help Prevent COVID-19? Data Remains Unsure
Autonomous AI-based System Compliant with Expert Consensus for AMD Treatment
Simulation Software Could Improve Teenage ADHD Driver Safety